0001752724-21-164707.txt : 20210811 0001752724-21-164707.hdr.sgml : 20210811 20210811100033 ACCESSION NUMBER: 0001752724-21-164707 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210531 FILED AS OF DATE: 20210811 DATE AS OF CHANGE: 20210811 EFFECTIVENESS DATE: 20210811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: T. Rowe Price Index Trust, Inc. CENTRAL INDEX KEY: 0000858581 IRS NUMBER: 000000000 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-05986 FILM NUMBER: 211162276 BUSINESS ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 BUSINESS PHONE: 410-345-2000 MAIL ADDRESS: STREET 1: 100 EAST PRATT STREET CITY: BALTIMORE STATE: MD ZIP: 21202 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INDEX TRUST INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: PRICE T ROWE INSTITUTIONAL EQUITY FUNDS INC DATE OF NAME CHANGE: 19900227 0000858581 S000069930 T. Rowe Price U.S. Limited Duration TIPS Index Fund C000222750 T. Rowe Price U.S. Limited Duration TIPS Index Fund-Z Class TLDZX C000222751 T. Rowe Price U.S. Limited Duration TIPS Index Fund TLDTX C000222752 T. Rowe Price U.S. Limited Duration TIPS Index Fund-I Class TLDUX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000858581 XXXXXXXX 811-05986 false false false N-1A S000069930 true T. ROWE PRICE INDEX TRUST, INC. 811-05986 0000858581 549300DT5TB0WREU3681 100 East Pratt Street Baltimore 21202 US-MD US 410-345-2000 State Street Corporation 1776 Heritage Drive Quincy 02171 617-786-3000 Custodian records for the Registrant. JPMorgan Chase Bank, London Woolgate House, Coleman Street London GB EC2P 2HD 0 44 20 7742 4000 Records related to the custody of Registrant's portfolio securities which are purchased outside the United States. The Bank of New York Mellon 103 Bellevue Parkway Wilmington 19809 800-441-9800 Fund accounting records. T. Rowe Price Services, Inc. 100 East Pratt Street Baltimore 21202 410-345-2000 Transfer, dividend disbursing, and shareholder service records. T. Rowe Price Index Trust, Inc. 100 East Pratt Street Baltimore 21202 410-345-2000 All accounts, books, and other documents required to be maintained by the Registrant under Section 31(a) of the Investment Company Act of 1940 and the rules thereunder. N N N-1A 6 Y Bruce W. Duncan N/A N Teresa Bryce Bazemore N/A N John G. Schreiber N/A N Robert W. Sharps N/A Y Paul F. McBride N/A N Robert J. Gerrard, Jr. N/A N Ronald J. Daniels N/A N David Oestreicher 004594569 Y John R. Gilner 001909214 100 East Pratt Street Baltimore 21202 XXXXXX N N N N N N N T. Rowe Price Investment Services, Inc. 008-25130 000008348 N/A Y N PricewaterhouseCoopers LLP 238 5493002GVO7EO8RNNS37 N N N N N N N T. Rowe Price U.S. Limited Duration TIPS Index Fund S000069930 549300H9945456GGYS20 Y 3 3 0 N N 0.01000000 -0.12000000 0.78000000 0.78000000 N N Y N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 12d1-1 (17 CFR 270.12d1-1) Y Y Y N T. Rowe Price Associates, Inc. 801-00856 000105496 7HTL8AEQSEDX602FBU63 N T. Rowe Price Services, Inc. 084-01079 N/A Y N T. Rowe Price Retirement Plan Services, Inc. 084-01917 N/A Y Y N ICE Data Services 13-3668779 Tax ID N Refinitiv US Holdings Inc. 549300NF240HXJO7N016 N Markit North America, Inc. N/A N Bloomberg Finance L.P. 5493001KJTIIGC8Y1R12 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) JPMorgan Chase Bank, London 7H6GLXDRUGQFU57RNE97 GB N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) EUROCLEAR BANK SA/NV 549300OZ46BRLZ8Y6F65 BE N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) JPMorgan Chase Bank, N.A. 7H6GLXDRUGQFU57RNE97 N Y Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N T. Rowe Price Retirement Plan Services, Inc. N/A Y Y T. Rowe Price Services, Inc. N/A Y N N T. Rowe Price Associates, Inc. 7HTL8AEQSEDX602FBU63 Y N N T. Rowe Price Investment Services, Inc. 008-25130 000008348 N/A 0.00000000 Citigroup, Inc. 008-08177 000007059 6SHGI4ZSSLCXXQSBB395 7885.00000000 The Goldman Sachs Group, Inc. N/A N/A 784F5XWPLTWKTBV3E584 11154.00000000 JP MORGAN CHASE & CO. N/A N/A 8I5DZWZKVSZI1NUHU748 7087.00000000 Morgan Stanley N/A N/A IGJSJL3JD5P30I6NJZ34 5947.00000000 32073.00000000 UBS Group AG N/A N/A 549300SZJ9VS8SGXAN81 CH 162180064.00000000 JP MORGAN CHASE & CO. N/A N/A 8I5DZWZKVSZI1NUHU748 130545615.00000000 Credit Suisse Group AG N/A N/A 549300506SI9CRFV9Z86 CH 54405392.00000000 Citigroup, Inc. 008-08177 000007059 6SHGI4ZSSLCXXQSBB395 189537834.00000000 Deutsche Bank Aktiengesellschaft N/A N/A 7LTWFZYICNSX8D621K86 DE 172653739.00000000 BARCLAYS PLC N/A N/A 213800LBQA1Y9L22JB70 GB 271201746.00000000 HSBC HOLDINGS PLC N/A N/A MLU0ZO3ML4LN2LL2TL39 GB 111636455.00000000 Wells Fargo & Company N/A N/A PBLD0EJDB5FWOLXP3B76 240651876.00000000 Credit Agricole Corporate and Investment Bank N/A N/A 1VUV7VQFKUOQSJ21A208 FR 582098293.00000000 Nomura Holdings, Inc. N/A N/A 549300B3CEAHYG7K8164 JP 144113434.00000000 2187425859.00000000 N 584287892.00000000 0.00000000 N N N N false false true false false false INTERNAL CONTROL RPT 2 g1aiii_trp_indextrust.htm PDFtoHTML Conversion Output

Report of Independent Registered Public Accounting Firm

To the Board of Directors of T. Rowe Price Index Trust, Inc. and Shareholders of T. Rowe Price U.S. Limited Duration TIPS Index Fund

In planning and performing our audit of the financial statements of T. Rowe Price U.S. Limited Duration TIPS Index Fund (constituting T. Rowe Price Index Trust, Inc., hereafter collectively referred to as the "Funds") as of and for the year ended May 31, 2021, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Funds' internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Funds' internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Funds' internal control over financial reporting.

The management of the Funds is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

PricewaterhouseCoopers LLP, 100 East Pratt Street, Suite 2600, Baltimore, Maryland 21202-1096 T: 410 783 7600, www.pwc.com/us

Our consideration of the Funds' internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Funds' internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of May 31, 2021.

This report is intended solely for the information and use of the Board of Directors of T. Rowe Price Index Trust, Inc. and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

Baltimore, Maryland

July 20, 2021

2